Atlas Trials

Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy

Clinical trial NCT05334849 · COMPLETED

Trial details

NCT number
NCT05334849
Sponsor
Lin Chen
Status
COMPLETED
Study type
OBSERVATIONAL
Advanced Gastric CarcinomaImmunotherapy
Start date
2018-11-01
Primary completion
2022-08-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.